血液转录组状态转移模型预测慢性髓性白血病的疾病演变与治疗反应
研究基于四环素关闭(Tet-Off)BCR::ABL诱导转基因小鼠及野生型对照的时序血液样本,构建慢性髓性白血病(CML)状态空间与三势阱白血病潜能景观,状态转移模型仅用最早时间点即可准确预测疾病进展与治疗反应,提示该策略或有助于在表型改变可检出前定时临床干预。
要点
- 基于血液转录组构建的CML状态空间与三势阱潜能景观可定义可观测疾病状态。
- 早期状态以抗CML基因占优,晚期状态以促CML基因占优,表达模式与潜能景观相似的基因被识别为疾病转变驱动基因。
- 仅用最早时间点作初始条件,状态转移模型准确预测疾病进展与治疗反应。
核心结论
- 转录组状态转移模型可准确预测癌症演变与治疗反应,支持其作为在表型改变可检出前定时临床干预的潜在有价值方法。
研究设计与样本
- 研究收集四环素关闭(Tet-Off)BCR::ABL诱导转基因小鼠与野生型对照的时序血液样本。
- 从转录组构建CML状态空间与三势阱白血病潜能景观,以潜能景观的稳定临界点定义可观测疾病状态。
主要发现
- 早期疾病状态以对抗白血病的抗CML基因占特征,晚期疾病状态以促CML基因占特征。
- 表达模式与潜能景观形状相似的基因被识别为疾病转变的驱动基因。
- 重新给予四环素沉默BCR::ABL基因后,患病小鼠转录组回到接近健康状态但未达到健康状态,提示部分转变不可逆。
- 酪氨酸激酶抑制剂(TKI)仅将转录组逆转到中间疾病状态而未接近健康状态,治疗后不久即出现疾病复发。
- 仅以最早时间点作为初始条件,状态转移模型准确预测了疾病进展与治疗反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic myeloid leukemia (CML) is initiated and maintained by BCR::ABL which is clinically targeted using tyrosine kinase inhibitors (TKIs). TKIs can induce long-term remission but are also not curative. Thus, CML is an ideal system to test our hypothesis that transcriptome-based state-transition models accurately predict cancer evolution and treatment response. We collected time-sequential blood samples from tetracycline-off (Tet-Off) BCR::ABL-inducible transgenic mice and wild-type controls. From the transcriptome, we constructed a CML state-space and a three-well leukemogenic potential landscape. The potential's stable critical points defined observable disease states. Early states were characterized by anti-CML genes opposing leukemia; late states were characterized by pro-CML genes. Genes with expression patterns shaped similarly to the potential landscape were identified as drivers of disease transition. Re-introduction of tetracycline to silence the BCR::ABL gene returned diseased mice transcriptomes to a near healthy state, without reaching it, suggesting parts of the transition are irreversible. TKI only reverted the transcriptome to an intermediate disease state, without approaching a state of health; disease relapse occurred soon after treatment. Using only the earliest time-point as initial conditions, our state-transition models accurately predicted both disease progression and treatment response, supporting this as a potentially valuable approach to time clinical intervention, before phenotypic changes become detectable.
引用
- Frankhouser DE, Rockne RC, Uechi L, et al. State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemia. Leukemia. 2024. PMID: 38307941. doi:10.1038/s41375-024-02142-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。